急性髓系白血病（Acute Myeloid Leukemia, AML）作为一种高异质性血液恶性肿瘤，给患者带来了巨大的治疗挑战。根据统计数据，AML在各类白血病中占据28%的比例，然而，五年生存率仅为31.7%。这一现状令人堪忧，突显出探索更有效的治疗方案的必要性。近日，中国科学院上海药物研究所的研究团队与海军军医大学第一附属医院合作，发布了中国人群首个急性髓系白血病组学全景数据库。这项研究不仅 ...

Discover how umbilical cord blood infusions offer a promising treatment for elderly acute myeloid leukemia patients, ...

Managing a younger person with a myeloproliferative neoplasm (MPN) includes a lot of long-term considerations, including ...

The wife of former Syrian President Bashar Assad, Asma, is experiencing a relapse of leukemia (an oncological malignant blood ...

DelveInsight's“Acute Myeloid Leukemia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Acute Myeloid Leukemia, historical and forecasted ...

With a projected Compound Annual Growth Rate (CAGR) of $% during the forecast period (2022-2028), the US AML market is well-positioned for substantial progression, underpinned by the convergence of ...

ALBAWABA - The wife of ousted Syrian President Bashar Assad, Asma has been given a "50/50" chance of survival after being ...

With the Oncology Brothers, Uma Borate, MD, discusses how CPX-351 demonstrates superior efficacy over 7+3 chemotherapy in ...

INR:4650. blackjack betting system that works Complete remission rate is 62%; Phase 2 clinical results of innovative therapy for acute myeloid ...